Providing Sound Science to Toxicology Issues








BioTox has managed and prepared the following individual projects:

  • >200 Toxicological Profiles
  • >10 Proposition 65 Assessments
  • >20 Occupational Exposure Limits (OELs)
  • >25 Risk Assessments
  • >10 No Significant Risk Levels (NSRLs) 
  • >18 GRAS self determinations
  • numerous SDSs
  • numerous REACH evaluations
  • numerous LHAMA evaluations
In addition, Dr. Kapp has acted as Study Director on >500 studies in private industry for numerous clients and has testified or been deposed in 25 legal cases.  He has also been involved with many Government and Industrial Panels and Committees and many other projects too numerous to be included in this summary. 


1989 - present

President/Principal Scientist

  • Toxicology consultation service in designing protocols, placing, implementing and monitoring programs. The company's principal has numerous direct interactions with trade organizations, animal welfare groups, governmental agencies, manufacturers, academia, and the legal community.
  • Special hands on experience in laboratory facility design, oversight, organization and management. 
  • Scientific specialties include evaluation, placement and monitoring of the following:
    • Chronic/Carcinogenicity/Subchronic Studies
    • Genetic Toxicology
    • Reproduction/Developmental Toxicology
Other services available:
  • GRAS Panels submissions to FDA
  • Various Toxicological Aspects of the Petrochemical Industry
  • Expert Witness Testimony/Deposition
  • Facility Review
  • Laboratory Organization and Design Compliance with Good Laboratory Practice
  • Industrial Hygiene Evaluation
  • Protocol Evaluation/Preclinical and Clinical Study Monitoring
    • BioTox has managed >$20MM in worldwide laboratory testing in the US, Europe, China and Brazil.
  • MSDS creation and maintenance - Global Compliance - EU, WHMIS, Japan, US.
  • Regulatory Compliance Including:
    • FDA (IND, FCN, 510K, GRAS)
    • EPA (FIFRA, PMN) 
    • OECD (REACH)
    • OSHA (Labeling and Testing)
    • CPSC (Labeling and Testing)
  • Industry Task Force Management and Representation
  • Environmental Affairs
  • SIDS Dossiers and SIAR Preparation
  • General Toxicology Counsel

1979 – 1989 
Director, Toxicology Laboratory
Exxon Biomedical Sciences, Inc.
Mettlers Road, CN 2350
East Millstone, NJ 08875-2350
Staff of approximately 140 including 15 Ph.D.’s and 25 contract employees:
  • 10 Department Managers
  • 100,000 square foot facility
  • 95% of Exxon Corporation toxicology testing performed at this site
  • Initiated, marketed and maintained a $3 million plus third party testing program with pharmaceutical, agricultural, and food products firms.
  • Interaction with new products/formulations for review by EPA, FDA, CPSC, and/or the DOT and for international agencies such as the European Economic Community (EEC).
  • Close working relations and understanding of Quality Assurance and the GLP regulations.
  • Acted as primary interface between Exxon scientific staff and Exxon laboratory staff and was the primary interaction with all third party clients.
  • Departments included all phases of mammalian and environmental toxicology including acute, subchronic, chronic, reproduction, and developmental projects.
  • Direct stewardship responsibilities of manpower, fiscal budgets, project assignments, staff training, and future direction of the laboratory.

1978 – 1979 
Senior Staff Toxicologist
Toxicology Department
Hazleton Laboratories America, Inc. (now Covance)
Vienna, Virginia
  • Staff of 25
  • 2 professional managers
  • Expanded responsibilities to include long term carcinogenicity and mutagenicity studies.
  • Personally directed about 175 scientific projects (scientific and fiscal responsibility).
  • Set up the company's first Genetic Toxicology Department.
1973 – 1977 
Staff Toxicologist
Toxicology Department
Hazleton Laboratories America, Inc. (now Covance)
Vienna, Virginia
  • Staff of 15
  • Responsible for all Acute, Reproduction and Genetic studies - scheduling/budgeting.
  • Personally directed over 150 scientific projects (scientific and fiscal responsibility).
1970 – 1972 
Corpsman, US Navy
Head, Cytogenetics Division
Anatomical Pathology
National Naval Medical Center
Bethesda, Maryland
  • 3 person staff
  • Responsible for the set up, financial and technical control of the US Navy's only worldwide cytogenetics laboratory.
  • Provided assistance with medical interpretation of genetic tests and reports of the genetics center laboratory.
  • Coordinated research activities between the National Institute of Medical Research (NMRI) and the National Institutes of Health (NIH).
1968 - 1970
US Navy
  • Vietnam Era Assignments